| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2007 | 2006 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 662 | 2019 |
| 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. S Meltzer, L Leiter, D Daneman, HC Gerstein, D Lau, S Ludwig, JF Yale, ... CMAJ: Canadian Medical Association journal= journal de l'Association …, 1998 | 633 | 1998 |
| Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease JF Yale, G Bakris, B Cariou, D Yue, E David‐Neto, L Xi, K Figueroa, ... Diabetes, Obesity and Metabolism 15 (5), 463-473, 2013 | 525 | 2013 |
| Pragmatic adjudication RA Posner Cardozo L. Rev. 18, 1, 1996 | 275 | 1996 |
| Impact of a computer-based patient record system on data collection, knowledge organization, and reasoning VL Patel, AW Kushniruk, S Yang, JF Yale Journal of the American Medical Informatics Association 7 (6), 569-585, 2000 | 273 | 2000 |
| Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management LA Leiter, JF Yale, JL Chiasson, S Harris, P Kleinstiver, L Sauriol Can J Diabetes 29 (3), 186-192, 2005 | 255 | 2005 |
| Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial JS Skyler, RS Weinstock, P Raskin, JF Yale, E Barrett, JE Gerich, ... Diabetes care 28 (7), 1630-1635, 2005 | 243 | 2005 |
| A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin … HC Gerstein, JF Yale, SB Harris, M Issa, JA Stewart, E Dempsey Diabetic Medicine 23 (7), 736-742, 2006 | 241 | 2006 |
| Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease JF Yale, G Bakris, B Cariou, J Nieto, E David‐Neto, D Yue, E Wajs, ... Diabetes, Obesity and Metabolism 16 (10), 1016-1027, 2014 | 202 | 2014 |
| Pharmacologic management of type 2 diabetes W Harper, M Clement, R Goldenberg, A Hanna, A Main, R Retnakaran, ... Canadian Journal of Diabetes 37, S61-S68, 2013 | 191 | 2013 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 178 | 2019 |
| Effect of acarbose on insulin sensitivity in elderly patients with diabetes. GS Meneilly, EA Ryan, J Radziuk, DC Lau, JF Yale, J Morais, ... Diabetes care 23 (8), 1162-1167, 2000 | 170 | 2000 |
| Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes V Papademetriou, L Lovato, M Doumas, E Nylen, A Mottl, RM Cohen, ... Kidney international 87 (3), 649-659, 2015 | 160 | 2015 |
| Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis AP Bevan, PG Drake, JF Yale, A Shaver, BI Posner Vanadium Compounds: Biochemical and Therapeutic Applications, 49-58, 1995 | 155 | 1995 |
| Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease MS Goldberg, RT Burnett, JF Yale, MF Valois, JR Brook Environmental research 100 (2), 255-267, 2006 | 150 | 2006 |
| Type 2 diabetes mellitus management in Canada: is it improving? LA Leiter, L Berard, CK Bowering, AY Cheng, KG Dawson, JM Ekoé, ... Canadian journal of diabetes 37 (2), 82-89, 2013 | 149 | 2013 |
| SGLT2 inhibitor–associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis RM Goldenberg, LD Berard, AYY Cheng, JD Gilbert, S Verma, VC Woo, ... Clinical Therapeutics 38 (12), 2654-2664. e1, 2016 | 147 | 2016 |
| Problems in transition from pediatric care to adult care for individuals with diabetes D Pacaud, JF Yale, D Stephure, R Trussell, HD Davies Canadian journal of Diabetes 29 (1), 13-18, 2005 | 130 | 2005 |
| The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: a multicenter … JF Yale, TR Valiquett, MN Ghazzi, JK Owens-Grillo, RW Whitcomb, ... Annals of internal medicine 134 (9_Part_1), 737-745, 2001 | 125 | 2001 |
